Ibuprofen B. Braun (Ibuprofen)

Ibuprofen, an NSAID, reduces pain, fever and inflammation by inhibiting cyclooxygenase enzymes.

• Pain: Provides analgesia for mild to moderate acute pain, including postoperative and trauma‑related discomfort.
• Fever: Reduces elevated body temperature in febrile states, helping to normalize thermoregulation during infection or inflammation.
• Inflammation: Decreases inflammatory response in musculoskeletal conditions such as sprains, strains and postoperative swelling.
• Post‑operative pain: Controls pain and inflammation after surgical procedures, facilitating early mobilization and recovery.
• Pediatric fever and inflammation: Provides safe and effective temperature control and anti‑inflammatory effect in children.

• Ibuprofen reversibly inhibits both cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, leading to reduced synthesis of prostaglandins and thromboxanes. This decrease in prostaglandin production diminishes peripheral sensitization of nociceptors, lowers the hypothalamic set‑point for temperature, and limits inflammatory vascular responses, thereby producing analgesic, antipyretic, and anti‑inflammatory effects.

Ibuprofen may cause a range of adverse reactions, varying from mild and transient to serious and potentially life‑threatening.

Common Side Effects

• Nausea: mild stomach upset or queasiness.
• Dyspepsia: indigestion, heartburn, or upper abdominal discomfort.
• Headache: transient cranial discomfort.
• Dizziness: feeling light‑headed or unsteady.
• Injection site reactions: redness, swelling, or pain at the infusion site.

Serious or Rare Side Effects

• Gastrointestinal bleeding: severe ulceration or hemorrhage that may appear as black stools or vomiting blood.
• Anaphylaxis: acute allergic reaction with rash, swelling, airway compromise and possible shock.
• Renal failure: sudden loss of kidney function, shown by reduced urine output and rising creatinine.
• Stevens‑Johnson syndrome: rare severe skin reaction with blistering and mucosal involvement.

When using ibuprofen injectable solution, clinicians should observe several precautionary measures to minimize risks.

• Renal function: assess baseline renal status and monitor creatinine during therapy.
• Bleeding risk: avoid in patients with active peptic ulcer disease or coagulopathy.
• Cardiovascular: use cautiously in patients with hypertension, heart failure or coronary artery disease.
• Pregnancy: evaluate risk‑benefit; generally avoided in the third trimester.
• Drug interactions: review concomitant NSAIDs, anticoagulants, ACE inhibitors and lithium.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofen may interact with several medicines, altering efficacy or increasing toxicity.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): ibuprofen may potentiate anticoagulant effect, leading to increased bleeding risk.
• Other NSAIDs or COX‑2 inhibitors: combined use adds gastrointestinal irritation and ulcer risk.
• Corticosteroids: concurrent therapy heightens chance of gastric ulceration and bleeding.
• Lithium: ibuprofen can reduce renal clearance of lithium, potentially causing toxicity.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: ibuprofen may impair renal prostaglandin synthesis, decreasing kidney perfusion; monitor renal function.
• Methotrexate: ibuprofen can lower renal elimination of methotrexate, raising plasma levels and risk of toxicity.